These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1260 related items for PubMed ID: 18614865

  • 1. Chemokine (C-C motif) receptor 5-using envelopes predominate in dual/mixed-tropic HIV from the plasma of drug-naive individuals.
    Irlbeck DM, Amrine-Madsen H, Kitrinos KM, Labranche CC, Demarest JF.
    AIDS; 2008 Jul 31; 22(12):1425-31. PubMed ID: 18614865
    [Abstract] [Full Text] [Related]

  • 2. Differences in molecular evolution between switch (R5 to R5X4/X4-tropic) and non-switch (R5-tropic only) HIV-1 populations during infection.
    Mild M, Kvist A, Esbjörnsson J, Karlsson I, Fenyö EM, Medstrand P.
    Infect Genet Evol; 2010 Apr 31; 10(3):356-64. PubMed ID: 19446658
    [Abstract] [Full Text] [Related]

  • 3. Epidemiology and predictive factors for chemokine receptor use in HIV-1 infection.
    Moyle GJ, Wildfire A, Mandalia S, Mayer H, Goodrich J, Whitcomb J, Gazzard BG.
    J Infect Dis; 2005 Mar 15; 191(6):866-72. PubMed ID: 15717260
    [Abstract] [Full Text] [Related]

  • 4. The impact of HIV tropism on decreases in CD4 cell count, clinical progression, and subsequent response to a first antiretroviral therapy regimen.
    Waters L, Mandalia S, Randell P, Wildfire A, Gazzard B, Moyle G.
    Clin Infect Dis; 2008 May 15; 46(10):1617-23. PubMed ID: 18419499
    [Abstract] [Full Text] [Related]

  • 5. HIV-1 chemokine coreceptor utilization in paired cerebrospinal fluid and plasma samples: a survey of subjects with viremia.
    Spudich SS, Huang W, Nilsson AC, Petropoulos CJ, Liegler TJ, Whitcomb JM, Price RW.
    J Infect Dis; 2005 Mar 15; 191(6):890-8. PubMed ID: 15717264
    [Abstract] [Full Text] [Related]

  • 6. HIV type 1 chemokine coreceptor use among antiretroviral-experienced patients screened for a clinical trial of a CCR5 inhibitor: AIDS Clinical Trial Group A5211.
    Wilkin TJ, Su Z, Kuritzkes DR, Hughes M, Flexner C, Gross R, Coakley E, Greaves W, Godfrey C, Skolnik PR, Timpone J, Rodriguez B, Gulick RM.
    Clin Infect Dis; 2007 Feb 15; 44(4):591-5. PubMed ID: 17243065
    [Abstract] [Full Text] [Related]

  • 7. Prevalence of CXCR4 tropism among antiretroviral-treated HIV-1-infected patients with detectable viremia.
    Hunt PW, Harrigan PR, Huang W, Bates M, Williamson DW, McCune JM, Price RW, Spudich SS, Lampiris H, Hoh R, Leigler T, Martin JN, Deeks SG.
    J Infect Dis; 2006 Oct 01; 194(7):926-30. PubMed ID: 16960780
    [Abstract] [Full Text] [Related]

  • 8. Coreceptor tropism in human immunodeficiency virus type 1 subtype D: high prevalence of CXCR4 tropism and heterogeneous composition of viral populations.
    Huang W, Eshleman SH, Toma J, Fransen S, Stawiski E, Paxinos EE, Whitcomb JM, Young AM, Donnell D, Mmiro F, Musoke P, Guay LA, Jackson JB, Parkin NT, Petropoulos CJ.
    J Virol; 2007 Aug 01; 81(15):7885-93. PubMed ID: 17507467
    [Abstract] [Full Text] [Related]

  • 9. Absence of coreceptor switch with disease progression in human immunodeficiency virus infections in India.
    Cecilia D, Kulkarni SS, Tripathy SP, Gangakhedkar RR, Paranjape RS, Gadkari DA.
    Virology; 2000 Jun 05; 271(2):253-8. PubMed ID: 10860879
    [Abstract] [Full Text] [Related]

  • 10. Co-receptor switch during HAART is independent of virological success.
    Saracino A, Monno L, Cibelli DC, Punzi G, Brindicci G, Ladisa N, Tartaglia A, Lagioia A, Angarano G.
    J Med Virol; 2009 Dec 05; 81(12):2036-44. PubMed ID: 19856465
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. HIV envelope proteins differentially utilize CXCR4 and CCR5 coreceptors for induction of apoptosis.
    Yao Q, Compans RW, Chen C.
    Virology; 2001 Jun 20; 285(1):128-37. PubMed ID: 11414813
    [Abstract] [Full Text] [Related]

  • 14. Determination of HIV-1 coreceptor tropism in clinical practise.
    Foeglein A, Walter H.
    Eur J Med Res; 2007 Oct 15; 12(9):473-82. PubMed ID: 17933729
    [Abstract] [Full Text] [Related]

  • 15. Use of GPR1, GPR15, and STRL33 as coreceptors by diverse human immunodeficiency virus type 1 and simian immunodeficiency virus envelope proteins.
    Edinger AL, Hoffman TL, Sharron M, Lee B, O'Dowd B, Doms RW.
    Virology; 1998 Sep 30; 249(2):367-78. PubMed ID: 9791028
    [Abstract] [Full Text] [Related]

  • 16. Viral evolution in macaques coinfected with CCR5- and CXCR4-tropic SHIVs in the presence or absence of vaccine-elicited anti-CCR5 SHIV neutralizing antibodies.
    Burke B, Derby NR, Kraft Z, Saunders CJ, Dai C, Llewellyn N, Zharkikh I, Vojtech L, Zhu T, Srivastava IK, Barnett SW, Stamatatos L.
    Virology; 2006 Nov 25; 355(2):138-51. PubMed ID: 16920175
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor.
    Weissman D, Rabin RL, Arthos J, Rubbert A, Dybul M, Swofford R, Venkatesan S, Farber JM, Fauci AS.
    Nature; 1997 Oct 30; 389(6654):981-5. PubMed ID: 9353123
    [Abstract] [Full Text] [Related]

  • 19. [Chemokine receptors and its importance in the replication cycle of human immunodeficiency virus: clinical and therapeutic implications].
    Azevedo-Pereira JM, Santos-Costa Q.
    Acta Med Port; 2008 Oct 30; 21(5):497-504. PubMed ID: 19187693
    [Abstract] [Full Text] [Related]

  • 20. Tropism switch in patients infected with HIV-1 and its clinical implications for the treatment with CCR5-receptor inhibitors.
    Arastéh K, Stocker H.
    Eur J Med Res; 2007 Oct 15; 12(9):397-402. PubMed ID: 17933720
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 63.